{
  "id": "icd11#screening_cues_3f7e7372",
  "title_en": "General — Screening Cues",
  "title_vi": "General — Dấu hiệu sàng lọc",
  "text_en": "Disorders due to substance use or addictive behaviours 499 6C48.Y Other specified disorder due to use of caffeine 6C49.Y Other specified disorder due to use of hallucinogens 6C4A.Y Other specified disorder due to use of nicotine 6C4B.Y Other specified disorder due to use of volatile inhalants 6C4C.Y Other specified disorder due to use of MDMA or related drugs, including MDA 6C4D.Y Other specified disorder due to use of dissociative drugs, including ketamine and PCP 6C4E.Y Other specified disorder due to use of other specified psychoactive substance, including medications 6C4F.Y Other specified disorder due to use of multiple specified psychoactive substances 6C4G.Y Other specified disorder due to use of unknown or unspecified psychoactive substances Essential (required) features • The presentation is characterized by psychological, cognitive or behavioural symptoms that develop during or soon after intoxication with or withdrawal from a specified substance, or use or discontinuation of a psychoactive medication. • The symptoms do not fulfil the diagnostic requirements for any other disorder in the disorders due to substance use grouping. • The intensity or duration of the symptoms is substantially in excess of disturbances that are characteristic of intoxication or withdrawal due to the specified substance. • The symptoms are not better accounted for by another mental disorder such as schizophrenia or another primary psychotic disorder, or a mood disorder. Evidence supporting a diagnosis of another mental disorder would include the symptoms preceding the onset of the substance use, the symptoms persisting for a substantial period of time after cessation of the substance or medication use or withdrawal (e.g. 1 month or more depending on the specific substance), or other evidence of a pre-existing mental disorder (e.g. a prior history of the symptoms not associated with substance use). • The symptoms are not a manifestation of another medical condition. • The symptoms result in significant distress or significant impairment in personal, family, social, educational, occupational or other important areas of functioning. If functioning is maintained, it is only through significant additional effort. Disorders due to psychoactive substance use, unspecified Available categories by substance class 6C40.Z Disorder due to use of alcohol, unspecified 6C41.Z Disorder due to use of cannabis, unspecified 6C42.Z Disorder due to",
  "gloss_vi": "Disorders due to substance use or addictive behaviours 499 6c48.y other specified disorder due to use of caffeine 6c49.y other specified disorder due to use of hallucinogens 6c4a.y other specified disorder due to use of ...",
  "source": "WHO ICD-11",
  "url": "https://icd.who.int/",
  "lang": "en",
  "axes": {
    "type": [
      "clinical",
      "everyday"
    ],
    "condition": [
      "General"
    ],
    "clinical_section": [
      "screening_cues",
      "psychoeducation",
      "do_not_do",
      "management",
      "caregiver"
    ],
    "life_topics": [
      "stress",
      "relationships"
    ],
    "advice_section": [
      "sleep_hygiene"
    ],
    "audience": [],
    "risk_band": "low"
  },
  "index_text": "General — Screening Cues General — Dấu hiệu sàng lọc Disorders due to substance use or addictive behaviours 499 6C48.Y Other specified disorder due to use of caffeine 6C49.Y Other specified disorder due to use of hallucinogens 6C4A.Y Other specified disorder due to use of nicotine 6C4B.Y Other specified disorder due to use of volatile inhalants 6C4C.Y Other specified disorder due to use of MDMA or related drugs, including MDA 6C4D.Y Other specified disorder due to use of dissociative drugs, including ketamine and PCP 6C4E.Y Other specified disorder due to use of other specified psychoactive substance, including medications 6C4F.Y Other specified disorder due to use of multiple specified psychoactive substances 6C4G.Y Other specified disorder due to use of unknown or unspecified psychoactive substances Essential (required) features • The presentation is characterized by psychological, cognitive or behavioural symptoms that develop during or soon after intoxication with or withdrawal from a specified substance, or use or discontinuation of a psychoactive medication. • The symptoms do not fulfil the diagnostic requirements for any other disorder in the disorders due to substance use grouping. • The intensity or duration of the symptoms is substantially in excess of disturbances that are characteristic of intoxication or withdrawal due to the specified substance. • The symptoms are not better accounted for by another mental disorder such as schizophrenia or another primary psychotic disorder, or a mood disorder. Evidence supporting a diagnosis of another mental disorder would include the symptoms preceding the onset of the substance use, the symptoms persisting for a substantial period of time after cessation of the substance or medication use or withdrawal (e.g. 1 month or more depending on the specific substance), or other evidence of a pre-existing mental disorder (e.g. a prior history of the symptoms not associated with substance use). • The symptoms are not a manifestation of another medical condition. • The symptoms result in significant distress or significant impairment in personal, family, social, educational, occupational or other important areas of functioning. If functioning is maintained, it is only through significant additional effort. Disorders due to psychoactive substance use, unspecified Available categories by substance class 6C40.Z Disorder due to use of alcohol, unspecified 6C41.Z Disorder due to use of cannabis, unspecified 6C42.Z Disorder due to Disorders due to substance use or addictive behaviours 499 6c48.y other specified disorder due to use of caffeine 6c49.y other specified disorder due to use of hallucinogens 6c4a.y other specified disorder due to use of ..."
}